Clinical Trial Update: Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining a biomarker-guided first-line immunotherapy combined with chemotherapy in advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Advanced Esophageal Cancer | Phase 2 | Status: UNKNOWN